ANRO vs MSFT: Which Stock is Better?
Side-by-side comparison of Alto Neuroscience Inc and Microsoft Corp in 2026
ANRO
Alto Neuroscience Inc
$20.70
MSFT
Microsoft Corp
$409.31
Key Metrics Comparison
| Metric | ANRO | MSFT | Winner |
|---|---|---|---|
| Market Cap | $644.94M | N/A | ANRO |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | 0.0% | 14.9% | MSFT |
| Gross Margin | 0.0% | 68.8% | MSFT |
Analyze ANRO
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ANRO or MSFT a better investment?
Comparing ANRO and MSFT: Alto Neuroscience Inc has a market cap of $644.94M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ANRO and MSFT?
ANRO (Alto Neuroscience Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ANRO or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ANRO or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.0% for ANRO.
Which company is more profitable: ANRO or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 0.0% for ANRO.
Which is the larger company: ANRO or MSFT?
Alto Neuroscience Inc (ANRO) is larger with a market cap of $644.94M compared to N/A for MSFT.
Should I buy ANRO or MSFT in 2026?
Both ANRO and MSFT have investment merit. ANRO trades at $20.70 while MSFT trades at $409.31. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ANRO and MSFT stock?
Key differences: Market Cap ($644.94M vs N/A), P/E Ratio (N/A vs 36.3x), Revenue Growth (0.0% vs 14.9%), Gross Margin (0.0% vs 68.8%).